ClinicalTrials.govpublic full text
Trial of an Alternative Cabozantinib Dosing Schedule in Metastatic Renal Cell Carcinoma and Neuroendocrine Tumors
metastatic renal cell carcinoma, clear-cell metastatic renal cell carcinoma, neuroendocrine tumors, carcinoid tumor, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 847753
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.